Compare FMC Corp (FMC) vs Procter & Gamble Co (PG) Price & Performance

FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.

The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.

Procter & Gamble (PG) trades at $150.28, up 2.85% over the past 24 hours, with technical indicators showing a neutral trend near key resistance at $150. The company reported steady revenue of $84.28B in 2025 and has beaten EPS estimates for three consecutive quarters, demonstrating resilient profitability with a net margin of 19.16%. Recent corporate developments include a new WNBA partnership and consistent dividend payments of $1.09 per share.

PG offers stability with strong cash flow and a 69-year dividend growth track record, but premium valuation multiples and modest revenue growth pose near-term upside limitations. Analyst consensus leans bullish with a $161.71 price target, though competitive pressures and economic sensitivity remain key risks for investors seeking defensive exposure.